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Abstract
Background: Oxidative stress (OS) has been linked to the pathology of a variety of chronic and degenerative
diseases. Medicinal plants contain bioactive compounds which are capable of preventing and fighting these
diseases. The nephroprotective and antioxidant properties of the aqueous leaf extract of Costus afer (C.afer) against
cyclosporine A CsA - induced nephrotoxicity in Wistar albino rats were investigated.
Methods: Six groups of five weight-matched animals each, were used for the study. The first and second groups
served as normal and toxic control and were given olive oil and CsA (50 mg/kg b.w.) orally respectively while
groups 3, 4, 5 and 6 ingested 375, 750 and 1125 mg/kg b.w. aqueous leaf extract and 100 mg/kg b.w. of the
Silymarin respectively one hour prior to administration of CsA 50 mg/kg b.w.
Results: Treatment with C. afer extract at doses of 375, 750 and 1125 mg/kg prevented the CsA induced
nephrotoxicity and oxidative impairments of the kidney, as evidenced by a significantly (p < 0.05) reduced plasma
creatinine, BUN, K+ and renal malondialdehyde (MDA). Furthermore, all the doses were able to induce a significant
increment (P < 0.05) of renal levels of glutathione (GSH) and plasma superoxide dismutase (SOD) activity,
catalase(CAT), glutathione-S-tranferase (GST), serum electrolytes (Na+ and HCO3
−), body and kidney weight. The
nephroprotective effects of C.afer extract were confirmed by a reduced severity of renal cellular damage.
Conclusion: Aqueous leaf extract of C.afer has a protective role against CsA- induced nephrotoxicity probably
mediated through its antioxidant properties.
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Background
Indiscrimate use of herbs in treating various diseases has
attracted the interest of many researchers in science and
medicine to undertake researches that will significantly
unfold the medical importance, mechanism of action as
well as toxic effect (if any) of these medicinal plants [1].
The organs mostly affected by toxins from medicinal
plants include Liver, heart and kidney [2, 3]. Nephrotox-
icity is the poisonous effect of some substances including
toxic chemicals and medication, on the kidneys charac-
terized by rapid serum creatinine increase and reduction
of glomerular filtration rate (GFR) and may be associated
with mild arterial hypertension. Histological changes in
renal biopsies reveal tubular, arterial and glomerular
changes as well as interstitial fibrosis [4, 5]. Three clinical
syndromes recognized in drug-induced nephropathy in-
clude acute renal failure, chronic interstitial nephritis and
nephritic syndrome [6, 7]. It can take years for the damage
to these organs to be noticeable because there are no
symptoms, which is why the kidney disease is often refer
to as “silent killer” [8, 9].
Cyclosporine A (CsA) is a potent immunosuppressant
used for the prevention of organ transplant rejection and
in the treatment of autoimmune diseases [10] has been
linked with several adverse effects including toxicities
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(nephrotoxicity, hepatoxicity and neurotoxicity), hyperten-
sion, dyslipidemia, gingival hyperplasia, hypertrichosis,
malignancies and increased risk of cardiovascular events
[11], both in transplant and non-transplant settings (auto-
immune disorders). Reactive oxygen species (ROS) pro-
duction and oxidative stress signaling has been implicated
in a variety of renal diseases such as IgA nephropathy and
chronic kidney disease [10]. Indiscriminate usage of C.
afer in treatment of diseases in Nigeria and many other
countries justify carrying this research and many of its
kind. Most medicinal plants used by people are almost
always taken in aqueous form either as cold or boiled
extract since it has also been reported that the aqueous
extract is less toxic than the organic extract [12] These
constituents of Costus afer (alkaloids, saponins, flavonoids,
tannins and phenols) are potent water soluble antioxidants
which prevent oxidizing cell damage [13, 14].
Therefore the present study will provide a premise for
the discovery of medicines which elicit their medicinal
effects through free radical scavenging as this is implicated
in a number of degenerative diseases.
Method
Plant collection
Costus afer leaves were collected from the Pharmacognosy
Garden of the Faculty of Pharmaceutical Sciences,
University of Port Harcourt in Ikwerre Local Government
Area of Rivers State, Nigeria in January, 2015.
Sample identification
The plant was taxonomically identified and authenticated
by A.O. Ozioko, International Centre for Ethnomedicine
and Drug Development (INTERCEDD), University of
Nigeria, Nsukka, Enugu State and Professor M.E. Bassey of
the Department of Botany, University of Uyo, Akwa Ibom
State, Nigeria. The voucher specimen for the same is con-
served under the reference number INTERCEDD/034.
Sample processing and extraction
The leaves was harvested from the stem, washed with
clean and shade dried at room temperature for three
days. Two hundred and fifty grams of the fresh leaves
was weighed chopped into small pieces and ground with
a blender. This was macerated in 500 ml of distilled
water placed in a stoppered container and allowed to
stand for 24 h with constant agitation. After 24 h, the
mixture was strained, the marc was pressed and the
liquid was filtered and stored in refrigerator at 4 °C. The
solution was discarded every 3 days and the process
repeated till the end of the study.
Drugs and chemicals
Silymarin (Silybon-70), Manufactured by Micro Labs
Ltd, Cyclosporine (Sandimmune®, Neoral®). Silymarin
was employed as a standard drug for nephroprotection
and antioxidant evaluation. Cyclosporine was used as
standard drug to induce nephrotoxicity. Other chemicals
and reagents used were of analytical grade.
Experimental animals
Thirty in-breed male Wistar albino rats (75.80 - 162.20 g)
acclamitised for two weeks were maintained under con-
trolled conditions of temperature (23 ± 2 °C) and humidity
(50 ± 5 %) and a 12-h light–dark cycle, were used for the
experiment. The animals were housed in sanitized poly-
propylene cages containing sterile paddy husk as bedding.
The bedding of the cages was changed daily and the cages
were cleaned as well. They had free access to standard rat
pellet diet and water ad libitum. All the experimental pro-
cedures were performed according to the committee for
the purpose of control and supervision of experiments on
animals, norms and approved by the Institutional Animal
Ethical Committee.
Acute toxicity studies
Rats were kept overnight fasting prior to drug adminis-
tration. Animals received a single oral dose (2,000 mg/
kg, body weight) of aqueous leaf extract of Costus afer.
After the administration of aqueous leaf extract of Cos-
tus afer, food was withheld for further 3–4 h. Animals
were observed individually at least once during the first
30 min after dosing, periodically during the first 24 h
(with special attention during the first 4 h) and daily
thereafter for a period of 14 days. Once daily cage side
observations included changes in skin and fur, eyes and
mucous membrane (nasal) and also respiratory rate, cir-
culatory (heart rate and blood pressure), autonomic
(salivation, lacrimation, perspiration, piloerection, urin-
ary incontinence, and defecation) and central nervous
system (ptosis, drowsiness, gait, tremors and convulsion)
changes. Mortality, if any, was determined over a period
of two weeks [15].
Selection of dose of the extract
LD50 was done as per OECD guidelines for fixing the
dose for biological evaluation. The LD50 of aqueous leaf
extract of costus afer leaf extract as per OECD guidelines
falls under class four values with no signs of acute tox-
icity at 2000 mg/kg. The biological evaluation was car-
ried out at three different dose range 375, 750 and
1125 mg/kg body weight representing (25, 50, 75 % of
1500 mg). All doses were given in the volume ranging
between 0.42 ml and 1.20 ml orally.
Cyclosporine-a induced nephrotoxicity in Rat
Thirty male Wistar albino rats were assigned to six weight
matched groups of five rats rats each. The experimental
period was 10 days.
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Group I: Animals were administered a single dose of
distil water (1 ml/kg, p.o.) daily for 5 days and received
olive oil (1 ml/kg, p. o.) for another five days.
Group II: Animals were administered distil water
(1 ml/kg, p.o.) once daily for 5 days and received
CsA:olive oil (1:1, 50 mg/kg, p. o.) for five days.
Group III: Animals received aqueous extract of Costus
afer (375 mg/kg, p.o.) once daily for 5 days and
received same dose of extract one hour prior to 50 mg/
kg CsA:olive oil p. o.) for another five days.
Group IV: Animals received aqueous extract of Costus
afer (750 mg/kg, p.o.) once daily for 5 days and
received same dose of extract one hour prior to 50 mg/
kg CsA:olive oil p. o.) for another five days.
Group V: Animals received aqueous extract of Costus
afer (1125 mg/kg, p.o.) once daily for 5 days and
received same dose of extract one hour prior to 50 mg/
kg CsA:olive oil p. o.) for another five days.
Group VI: Animals received silymarin (100 mg/kg, p.o.)
once daily for 5 days and received same dose of
silymarin one hour prior to 50 mg/kg CsA:olive oil p.
o.) for another five days.
Animals were sacrificed 24 h after the last treatment.
Blood was collected by retero orbital sinus puncture and
serum was separated by centrifugation. Rats were sacri-
ficed under ether anesthesia; kidney were excised, rinsed
clean in saline, weighed and preserved in 10 % formalin
for antioxidant assay and histopathological study.
Antioxidant assay
For antioxidant analysis, the kidney was minced into
small pieces and homogenzed with ice cold 0.05 M
potassium phosphate buffer (pH 7.4) to make 10 %
homogenates. The homogenates were centrifuged at
6000 rpm for 15 mins at 4 °C. The supernatant was
collected for the estimation of catalase (CAT) activity
using hydrogen peroxide as substrate according to the
method of Clairborne [16]. Superoxide dismutate
(SOD) was assayed by the method described by Misra
and Fridovich [17]. Glutathione-S-transferase (GST)
was assayed by the method of Habig et al. [18]. Re-
duced glutathione (GSH) was determined at 412 nm
using the method described by Sedlak and Lindsay
[19] lipid peroxidation was quantified as malondialde-
hyde (MDA) according to the method describe by
Ohkawa et al. [20] and the MDA level was calculated
according to the method of Todorova et al. [21] and
expressed as μmol MDA/mg protein.
Histopathological studies
Portion of the kidney from all the experimental groups
were fixed in 10 % formaldehyde, dehydrated in graded
alcohol, cleared in xylene and then embedded in paraffin.
Microtome sections (5 μm thick) were prepared from each
kidney sample and stained with heamtoxylin-eosin (H&E)
dye. The sections were examined for the pathological
findings.
Statistical analysis
The data obtained from the experiment was statistically
analyzed and expressed as Mean ± Standard deviation
(SD) using SPSS (Statistical package for social sciences)
and one-way analysis of variance (ANOVA) followed by
post-hoc Tukey test. Values of *p < 0.05 were considered
statistically significant.
creatinine, Na+ and HCO3-
Results
The result of the acute toxicity test carried out using
daily cage side observations of the animals, indicates no
changes in skin and fur, eyes and mucous membrane
(nasal) and also respiratory rate, circulatory (heart rate
and blood pressure), autonomic (salivation, lacrimation,
perspiration, piloerection, urinary incontinence, and
defecation) and central nervous system (ptosis, drowsiness,
gait, tremors and convulsion). There was no mortality.
Table 1 shows the effect of C. afer on the average
body, absolute and relative kidney weight, feed and fluid
intake of CsA induced nephrotoxic rat. There was no
significant change in average body weight, absolute and
relative weight of kidney, feed and fluid intake compared
with the normal control in all the groups. There was a
marked reduction in body weight gain of the toxic con-
trol group compared with other groups.
In CsA induced nephrotoxicity, ingestion of CsA re-
sulted in a significant increase in blood urea nitrogen
(BUN), serum creatinine and K+ whereas the serum Na+
and HCO3
− significantly (p<0.05) decreases compared to
normal control group. Administering aqueous leaf ex-
tract of C. afer significantlyreduced the level of BUN and
serum K + in a dose dependent manner (Table 2).
In CsA induced nephrotoxicity, treatment with CsA
causes a significant (p<0.05) increase in MDA while
GSH, CAT, GPA, SOD and GST significantly (p<0.05)
decreases as compared to normal control group. Admin-
istering aqueous leaf extract of C.afer significantly
(p<0.05) increase the GSH, CAT, GPA, SOD and GST in
CsA treated rats as compared to the toxic control (CsA
alone) and the MDA was significantly (p<0.05) decreased
(Table 3).
In CsA induce nephrotoxicity model normal control
rats (Fig. 1a) showed normal glomerular and tubular
histology whereas toxic control (CsA alone) group was
found to cause distorted tubular shape, cellular infiltration
of the tubules (tubulitis), glomerular and blood vessel con-
gestion, and also result in the presence of inflammatory
cells in kidney sections (Fig. 1b). The concurrent treatment
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with the aqueous leaf extract of C.afer dose dependently
reduced such changes in kidney histology (Fig. 1c, d and e).
Discussion
Nephrotoxicity has been previously documented by a
number of studies as the most common and clinically
significant as well as the most serious adverse effect of
cyclosporine [22, 23]. The exact mechanism of CsA-
induced nephrotoxicity remains obscure but several
studies suggest that a defect in intracellular calcium
handling, magnesium deficiency, oxidative stress, and ni-
tric oxide system are involved [24]. Nephrotoxicity due
to chronic cyclosporine-A treatment is widely attributed
to the generation of reactive oxygen species [25]. It was
demonstrated in this study that the administration of
50 mg/kg CsA for five consecutive days was able to in-
duce nephrotoxicity in rats. It is known that CsA causes
vasoconstriction by its direct action on the arterioles.
The vasoconstriction is reported to be due to CsA action
in blocking mitochondrial calcium release, inducing in-
creased intracellular calcium which causes vasoconstric-
tion [25]. In the present study, increased production of
lipid hydroperoxides and a significant decrease in total
antioxidants with CsA confirms the role of oxidative
stress in CsA induced organ toxicity. It could also be
said that the potential mediators of CsA-induced
vasoconstriction involves the renal sympathetic nerves,
others factors such as angiotensin II, reduced nitric
oxide production and alteration of prostaglandin- thromb-
oxane cascade may also account for the pathogenesis of
renal dysfunction [26].
Cyclosporine treatment to the rats toxic control
(Cyclosporin-A alone) group resulted in significant in-
crease in renal tissue (L-MDA) levels as compared with
the extract treated groups (p<0.05). Similarly Amudha et
al. showed significant increase in lipid peroxidation dur-
ing CsA administration which suggests the involvement
of reactive oxygen specie (ROS) in the pathogenesis of
renal injury. Elevated levels of MDA in renal tissue have
been regarded as an indicator for cellular damage due to
excess lipid peroxidation processes that occur during
malfunctioning of the antioxidant defence system [27].
In contrast, administration of the aqueous extract of C.
afer as well as silymarin one hour (1 h) before CsA admin-
istration prevented this elevation dose dependently. The
ability of C. afer to protect lipid peroxidation is in agree-
ment with Uboh et al. [28], who demonstrated that C. afer
leaf ’s juice possess remarkable lipid peroxidation inhib-
ition and radical scavenging activities.
Administration of cyclosporine to normal rats resulted
in a significant decrease in renal tissue antioxidant
(GSH, GST and SOD) activities as compared with control
Table 1 Effect of Costus afer on the average body, absolute and relative kidney weight, feed and fluid intake of CsA induced
nephrotoxic rat












NC (1 ml/kg water) 22.00(29.02 %) 97.80 ± 3.35 0.50 ± 0.08 0.51 ± 2.36 71.800 ± 9.46 182.80 ± 6.88
TC (CsA (50 mg/kg) 1.2 (0.9 %) 134.80 ± 3.56 0.70 ± 0.05 0.52 ±1.40 64.74 ± 13.24 152.80 ± 34.65
CsA+375 mg/kg CA
extract
12.00 (10.61 %) 125.00 ± 6.33 0.70 ± 0.02 0.56 ± 0.25 68.00 ± 9.97 170.00 ±9.72
CsA +750 mg/kg CA
extract
14 (12.99 %) 121.80 ± 5.81 0.63 ± 0.02 0.52± 0.38 60.70 ± 14.18 158.50 ± 22.736
CsA +1125 mg/kg CA
extract
13.00 (13.26 %) 111.00 ± 10.77 0.60 ± 0.07 0.54± 0.62 68.15 ± 5.51 178.20 ±7.24
CsA + 100 mg/
kgSilymarin
7.0 (4.50 %) 162.20 ± 5.07 0.80 ± 0.03 0.49± 0.611 54.30 ± 16.13 161.50 ± 24.95
All values represent Mean ± Standard deviation (n=5); RKW= AKW/BW×100(%), [RKW relative kidney weight, AKW absolute kidney weight, BW body weight], Body
Weight Gain(g) (initial –final BW), Percent weight gain in parentheses
CA costus afer, CsA cyclosporine-A
Table 2 Effect of aqueous leaf extract of C. afer on BUN, serum creatinine and electrolyte in experimental groups
Treatments Na (nmol/l) K(nmol/l) Cr (μmol/l) BUN (mmol/l) HCO3 (mmol/l)
NC 102.00±27.62bc 7.10 ± 0.10 457.00±73.19 1.40 ± .60b 27.33 ± 1.16
TC (CsA(50 mg/kg) 36.00± 4.00a 9.20± 1.15 481.33±116.43 4.70±0.98ac 24.67 ± 1.16
CsA+ 375 mg/kg extract 57.00± 7.55a 6.20 ±0.90b 463.33±41.79 2.13±0.12b 27.33 ± 1.16
CsA+ 750 mg/kg Extract 57.00 ± 7.55a 7.30± 1.25 414.67±64.39 1.63±0.55b 26.00 ± 2.00
CsA+ 1125 mg/kg Extract 58.00 ± 15.62a 5.70± 0.17b 381.33±63.50 2.87±0.70b 24.67 ± 1.16
CsA+ Silymarin (100 mg/kg) 75.33 ± 75.33b 7.47 ± .25 427.33±83.36 2.13± 0.70b 24.00 ± 2.00
All values represent Mean ± SD (n=5); a = p<0.05 vs Control; b = p<0.05 vs CsA alone; c=p<0.05 vs Silymarin. Cr (creatinine), Ur(blood urea nitrogen)
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group (p<0.05). A decrease in CAT and GPA levels which
is not significantly different (p=0.32 and 0.26 respectively)
when compared with the control group was also observed
in the CsA group. The effect of the CsA administration on
the alteration of the CAT and GPA activity exhibits
variability in different studies and is attributed to the
difference in dose, time and route of exposure in the
experimental design. The observed decrease in the
catalase activity in CsA treated rats is due to the de-
creased availability of NADPH which is required for













NC (water) 0.04±0.001bc 0.04± 0.002c 0.13±0.01 0.12±0.006 0.06±0.003bc 0.83±0.006ab
TC (CsA (50 mg/kg) 0.03±0.001ac 0.05±0.004c 0.11±0.01 0.12±0.006 0.05±0.002ac 0.82±0.012ac
CsA+ 375 mg/kg CA
Extract
0.04±0.002bc 0.03±.005ab 0.13±0.01 0.12±0E-7b 0.05±0.001a 0.76±0.006abc
CsA+ 750 mg/kg CA
Extract
0.034±0.001ac 0.03±0.003ab 0.13±0.01 0.13±0.006b 0.05±0.001a 0.80±0.006bc
CsA+ 1125 mg/kg CA
Extract
0.046±0.002b 0.02±0.001acb 0.14±0.01b 0.13±0.006 0.05±0.006ab 0.82±0.006b
CsA+ Silymarin
(100 mg/kg)
0.047±0.001ab 0.03±0.001ab 0.13±0.01 0.11 ± 0.006 0.05 ± 0.003ab 0.82±0.006b
All values represent Mean ± SD (n=5); a = p<0.05 vs NC; b = p<0.05 TC; c= p<0.05 vs Silymarin. NC normal control, TC toxic control
Fig. 1 Effect of aqueous leaf extract of Costus afer on Cyclosporin-A induced nephrotoxicity in rats. a: Normal control; b: Treated cyclosporin
(50 mg/kg, p. o.); c: Treated with Costus afer (375 mg/kg); d: Treated with Costus afer (750 mg/kg,); e: Treated with Costus afer (1125 mg/kg);
f: Treated with silymarin (100 mg/kg). (H & E X 200)
Ezejiofor et al. Clinical Phytoscience  (2016) 2:11 Page 5 of 7
catalase activity from its inactive form. Therefore, it is
possible that depletion of NADPH production during
CsA treatment could decrease the catalase activity.
Decrease in the activity of GPA during CsA administration
indicates the reduction in the levels of GSH and increase in
the levels of peroxides. The depletion of glutathione causes
a proportional decrease in hydrogen peroxide detoxification
by glutathione peroxidase. The decline in renal antioxidants
activity after CsA administration was in agreement with the
results reported by Uz et al. [29].
The antioxidants- catalase, SOD, GPA and GSH consti-
tute the major defence against ROS- induced oxidative
damage. Superoxide dismutase is considered as the first
line of defence against the harmful effects of oxygen radi-
cals in cells, where it scavenges ROS by catalysing the dis-
mutation of superoxide to hydrogen peroxide and oxygen
[30]. The administration of C. afer extract concomitantly
with cyclosporine resulted in significant increase in renal
tissue antioxidant activities as compared with CsA group.
These results are in agreement with the study of Anyasor
et al. [14] who reported that, the chloroform leaf extract
of C. afer could serve as a potential source of biopharma-
ceutical agents with antioxidative property as it was able
to restore the antioxidant levels to the control range.
Several important biochemical parameters were also
included in this toxicity study. These biological parame-
ters are indicators for organ toxicity. For example, kid-
ney functions were evaluated by means of serum urea,
creatinine and electrolyte. Increase of blood creatinine
has been shown to be a good indicator of negative im-
pact in kidney functions [31]. An increase in serum renal
function tests (urea and creatinine) concentrations were
observed in CsA treated rats as compared with control
group. The increase in serum urea concentration was
significant (p=0.001), while that of creatinine was not
significantly different (p=0.99) when compared with the
control group. These results are nearly in agreement
with the study of Tirkey et al. [24] (2005) who reported
that, chronic administration of CsA for 21 days caused a
marked impairment of renal function. High levels of
plasma urea and creatinine can be used as a rough index
of the glomerular filtration rate and indicates several dis-
turbances in kidney. The administration of C. afer aqueous
extract to cyclosporine treated rats exhibited a decrease in
serum renal function (urea and creatinine) levels as com-
pared with CsA group. Similarly, Uboh et al., [28] reported
that, administration of C. afer extract restored the levels of
plasma creatinine and urea to the control range.
Administration of Cyclosporine A rats in toxic control
(Cyclosporin-A alone) resulted in a significant decrease
in sodium. This result is nearly similar with the study of
Chia et al. [26] who found sodium depletion to be associ-
ated with CsA treatment. An increase in serum potassium
levels was also observed, however, this was not significantly
different (p=0.06) when compared with control group.
These results was in agreement with Petrussa et al., who
showed that serum potassium level was significantly higher
in the CsA group than in the control group and signifi-
cantly lower in the extract group than in the CsA group.
The hyperkalemia seen with calcineurin inhibition is likely
multifactorial and relates to inhibitory effects on Na-
K-ATPase in collecting ducts and possibly to distal
tubular acidosis [32]. Administration of C. afer extract
with CsA induced a significant increase in serum so-
dium levels and a decrease in potassium levels in the
CsA + Extract groups. Similarly, Ezejiofor et al. [33]
reported that C. afer significantly decreased serum sodium,
blood urea, and serum creatinine levels in gentamicin-
induced nephrotoxic rats. There was no significant differ-
ence in the serum bicarbonate level of the CsA group
when compared with the control group.
Histopathological studies were conducted on vital
organ (kidney) of all the rats. According to Wang et al.,
impaired organs often have abnormal atrophy [34]. The
results of this study also showed a marked effect of the
CsA administration in terms of the histopathological
damages caused on the kidney of the rats in CsA group.
The result showed the presence of inflammatory cells in
the kidney of the unprotected CsA- induced nephrotoxic
rat indicating interstitial inflammation. This is consistent
with the reports of Ebru et al. [29] of changes like afferent
arteriolopathy, interstitial fibrosis and tubular atrophy. No
structural changes were seen in the kidneys of the rats
which were given C. afer extracts in combination with CsA.
Generally, an increase or decrease in bodyweight of an
animal has been used as an indicator of adverse effect of
drugs and chemicals [35]. In addition to bodyweight,
relative organ weight has also been used as another basic
indicator to determine whether the rats have been ex-
posed to harmful agents [35, 36]. Their organs will tend
to swell or damage if they were subjected to toxic sub-
stances. This will subsequently alter their organ-to body
weight ratios as compared to the respective controls
[37]). CsA treatment produced a significant decrease in
body weight gain and consequently a decrease in the
kidney weight of the CsA group as compared with the
control group. This is in agreement with Tariq et al. [38]
who reported a decrease in the body weight of the ani-
mals in the CsA group. There was an increase in the
body weights of the animals in the extract group from
day 0 to day 5 as well as day 10 for both control and the
CsA + Extract groups. However, the increase in body
weight of the animals from day 5 to day10 in the CsA +
extract group was not as high as that of the control
group. A significant decrease in the food and fluid intake
was observed in the CsA group when compared with the
control group. These results are in line with the findings
of Ezejiofor et al. [33].
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Conclusion
Aqueous leaf extract of C.afer has a protective role
against CsA-induced nephrotoxicity probably mediated
through its antioxidant properties.
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